A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/166 (2006.01)
Patent
CA 2649701
Use of a ERRy agonist or pharmaceutically acceptable salt thereof, for the prevention, delay of progression or the treatment of diabetes, insulin resistance, metabolic disease/metabolic syndrome, dyslipidemia, obesity, overweight, Neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease or improvement of exercise endurance capacity.
L'invention concerne l'utilisation d'un agoniste du récepteur ERRy ou d'un sel acceptable sur le plan pharmaceutique de celui-ci, pour la prévention, le retardement de la progression ou le traitement du diabète, de la résistance à l'insuline, des maladies métaboliques/syndrome métabolique, de la dyslipidémie, de l'obésité, de la surcharge pondérale, des maladies neurodégénératives de type maladie de Parkinson, maladie d'Alzheimer, maladie de Huntington ou l'amélioration de la capacité d'endurance pendant l'exercice.
Rangwala Shamina M.
Stevenson Susan C.
Wu Zhidan
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Use of organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of organic compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2019378